68
Left Main Revascularization

Left main revascularization dr md toufiqur rahman DM FSCAI FRCP FAPSIC

Embed Size (px)

Citation preview

Left Main Revascularization

Dr. Md.Toufiqur Rahman MBBS, FCPS, MD, FACC, FESC, FRCP, FSCAI,

FCCP,FAPSC, FAPSIC, FAHA

Associate Professor of CardiologyNational Institute of Cardiovascular Diseases

Sher-e-Bangla Nagar, Dhaka-1207

Consultant, Medinova, Malbagh branchHonorary Consultant, Apollo Hospitals, Dhaka and

Life Care Centre, Dhanmondi

[email protected]

Left Main Revascularization

Definition of left main stenosis

[email protected]

Coronary RevascularizationPCI vs CABG

CABG PCI• POBA• Atherectomy• Extraction Devices• Distal Protection Devices• Intracoronary Stenting

– BMS and DES

• Arterial conduits• Off-pump• Minimally invasive• Vein harvest• Robotics• Hybrid Procedures

[email protected]

ESC guidelines 2010 – CABG vs. PCI • Left main (isolated or 1VD ,ostium/shaft)

- CABG = IA, PCI = IIa B • Left main (isolated or 1VD, distal bifurcation)

- CABG = IA, PCI = IIb B • Left main + 2VD or 3VD,SYNTAX score < 32

- CABG = IA, PCI = IIb B• Left main + 2VD or 3VD,SYNTAX score 33

- CABG = IA, PCI = III B* I/IIb/III = recommendation class, A/B = level of evidence

[email protected]

Guidelines summary• CABG gold standard but PCI good option in

ostial/shaft disease or when SYNTAX ≤ 22 and risk of surgical complications is relatively high

• PCI also acceptable in high surgical risk patients with distal LM disease or when SYNTAX ≤ 32

• PCI should not be performed in patients who can undergo CABG and have unfavourable anatomy (SYNTAX > 33)

[email protected]

5 yrs. results in the LM COMPARE trial, SJ Park et al. JACC Inter

[email protected]

PCI and CABG do not work by intention to treat

The most important issue is long term results

In PCI success is “WRONGLY” defined as successful stent placement

Optimal: IVUS confirmed stent placement, should be the gold standard

[email protected]

1. Occlusion of the LAD or of the RCA which cannot be opened by PCI and with viable myocardium. Chronic occlusion of the RCA and sometimes even of the LAD can left untreated in elderly people with reduced physical activity.

2. Complex and calcific distal left main bifurcation and the PCI operator does not feel confident to treat or she/he does not expect to obtain a good final result

3. Long diffuse disease in the proximal LAD (needs a stent longer than 30-35 mm) in a patient with diabetes mellitus

4. A patient who has or may have problems with dual antiplatelet therapy

Conditions were CABG may be a better choice compared to PCI in patients with Left Main Stenosis

[email protected]

Revascularization Spectrum of CareHigh

Restonotic Risk

High Thrombotic / Safety Risk

Multi-Vessel Disease, etc.

DAPT concerns, etc.

Bare Metal StentsCABG

ESC 2009 • Two- year Outcomes of the SYNTAX Trial • Kappetein • Slide 12

Repeat Revascularization to 2 YearsRepeat Revascularization to 2 Years

8.6%

17.4%

0 12 24Months Since Allocation

Cum

ulat

ive E

vent

Rat

e (%

)

ITT population

P<0.001

TAXUS (N=903)CABG (N=897)

Cumulative KM Event Rate ±1.5 SE; log- rank P value;*Binary rates

20

40Before 1 year*5.9% vs 13.5%

P<0.001

After 1 year*3.7%vs 5.6%

P=0.06

[email protected]

ARTS II: TLR and ST at 5 years

Patrick W. Serruys, JACC Vol. 55, No. 11, 2010

14.5% TLR and 8% ST rate in multi-vessel disease

[email protected]

BMS Binary Restenosis Rates in DES Randomized Trials

Modified from Granada JF. Stent metal alloys. New DES Platforms Does the metal alloy matter? BARBARA HUIBREGTSE, DVM, AND JUAN F. GRANADA, MDPresented at: 2010 Transcatheter Therapeutics annual meeting; September 21–25, 2010;Washington,DC.

[email protected]

Other Options: Hybrid OR

– CABG-LIMA– Robotic- LIMA– Role of the Hybrid

OR• Define Hybid OR• Define Needs• Define Users• Define Patients

[email protected]

drto

ufiq1

9711

@ya

hoo.

com

End point CABG (%) DES (%) p

MACCE 12.1 17.8 0.0015Death/MI/stroke 7.7 7.6 0.98Revascularization 5.9 13.7 <0.0001Stroke 2.2 0.6 0.003MI 3.2 4.8 0.11All-cause death 3.5 4.3 0.37

Serruys PW et al. European Society of Cardiology Congress 2008; September 1, 2008; Munich, Germany.

Main Results

from SYNTAX

[email protected]

Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease

Chang-Wook Nam MD, PhD⁎, †, Fabio Mangiacapra MD‡, Robert Entjes MD§, In-Sung Chung MD, PhD†, Jan-Willem Sels MD§, Pim A.L. Tonino MD, PhD§, Bernard De

Bruyne MD, PhD‡, Nico H.J. Pijls MD, PhD§, William F. Fearon MD⁎, , and FAME Study Investigators

• Applying the knowledge from FAME with SYNTAX– Anatomy and Physiology

• 497 FAME pts had SYNTAX Score prospectively collected • Only the “physiologic” significant lesions were scored• 32% of pts moved to a lower risk group• Only FSS and procedure time were independent variables of

1-yr MACE

J Am Coll Cardiol. 2011 Sep 13;58(12):1211-8

[email protected]

Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease

Outcomes by SYNTAX Score• (A)The rates of death or (MI) • (B) major adverse cardiac events (MACE),

as composite of death, MI, or repeat revascularization including repeat PCI or CABG according to SS and FSS.

• The rate of death or MI was significantly different in the FSS groups unlike the SS groups. The rate of MACE was increased for the highest-risk group

• This trend was attenuated in the FSS groups compared with the classic SS groups. *p < 0.01, **p < 0.001.

J Am Coll Cardiol. 2011 Sep 13;58(12):[email protected]

Left Main PCI

• PCI vs CABG Meta-analysis• 1,611 pts from 4 randomized clinical trials; 12 mo MACCE

– LEMANS (2008-52 PCI/35 DES/ 53 CABG)– SYNTAX ( Taxus DES, 357 PCI/348 CABG)– Boudroit, et al. (100 PCI/ 110 CABG-did not report CVA)– PRECOMBAT (Sirolimus DES, 300 PCI/300 CABG)– EXCEL (2,600 pts, Xience DES, 3 yr f/u, SYNTAX <32… ???)

• PCI non-significant 1yr MACCE, death and MI– Lower stroke– Higher rate of revascularization

Capodanno D, et al. JACC2011;58:1426-321-8 [email protected]

One-year outcomes in Left Main Patients Treated with PCI or CABG

End point PCI, n=809 (%) CABG, n=802 (%) p MACCE 14.5 11.8 0.11Death, MI,CVA 5.3 6.8

0.26Death 3.0 4.1

0.29MI 2.8 2.9

0.95CVA 0.1 1.7

0.013TVR 11.4 5.4 <0.001

Capodanno D, et al. JACC2011;58:1426-321-8

[email protected]

LMain• Long-term outcomes of PCI with DES versus CABG

UPLM • Meta-analysis of 24 studies published January

2000 to December 2012, 14,203 patients. No significant difference for all-cause mortality between PCI or CABG at 1 year (odds ratio [OR], 0.792; 95% confidence interval [CI], 0.53 to 1.19), 2 years (OR, 0.92; 95% CI, 0.67 to 1.26), 3 years (OR, 0.94; 95% CI, 0.6 to 1.48), 4 years (OR, 0.84; 95% CI, 0.53 to 1.33), and 5 years (OR, 0.79; 95% CI, 0.57 to 1.08).

Athappan G, Patvardhan E, Tuzcu ME, Ellis S, Whitlow P, Kapadia SR. Left Main CAD Stenosis. A meta-analysis of DES vs. CABG. JACC INT Dec 2013 6: 1219-30.

[email protected]

LMain• TVR was significantly higher for PCI and stroke

was significantly lower. Nonfatal MI showed a statistically significant lower trend in CABG patients at 1 year (OR, 1.62; 95% CI, 1.05 to 2.50), 2 years (OR, 1.6; 95% CI, 1.09 to 2.35), and 3 years (OR, 2.06; 95% CI, 1.36 to 3.1). There was no significant difference in combined major adverse cardiovascular and cerebrovascular events between the two groups.

• Conclusions: PCI with DES is a safe and durable alternative to CABG for UPLM stenosis in select patients at long-term follow-up.

Athappan G, Patvardhan E, Tuzcu ME, Ellis S, Whitlow P, Kapadia SR. Left Main CAD Stenosis. A meta-analysis of DES vs. CABG. JACC INT Dec 2013 6: 1219-30.

[email protected]

Consideration for Left Main PCI

• NERS Score/NERS Score II– More complicated but potentially more predictive

with reduction of variable from 54 to 16 (Chen, JACCINTV. 2013; 6:1233-41.

• Guidelines recommendation• Anatomic Location may be Key• Heart Team Approach• EXCEL Trial (2,600 pts, 3 yrs follow-up, DES vs

CABG for [email protected]

Figure 1. IVUS classification for LMCA bifurcation plaque distribution.

Oviedo C et al. Circ Cardiovasc Interv. 2010;3:105-112

Copyright © American Heart Association, Inc. All rights reserved.

[email protected]